Home

Robert IV Dickey

CIK 1466862 · Chief Financial Officer · last filed 2025-09-11

Robert IV Dickey is a Chief Financial Officer who has filed 8 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for HIND, was dated Sep 11, 2025. Across all open-market trades the lifetime net is +$1.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.8K

Companies

3

Total Filings

8

Lifetime Open-Market Net

$1.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HIND Chief Financial Officer 762 $2.30 $1.8K $0 1 2025-09-11
LISATA THERAPEUTICS, INC. (NBS) Delisted Chief Financial Officer 12,066 — — $0 5 2015-01-02
AIM ImmunoTech Inc. (HEB) Delisted Senior Vice President 2,500 — — $1.6K 2 2012-06-07

Recent Filings

8 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-09-11 HIND Grant (A) +762 $0 EDGAR
2015-01-02 LISATA THERAPEUTICS, INC. (NBS) Delisted Grant (A) +484 $1.6K EDGAR
2014-08-01 LISATA THERAPEUTICS, INC. (NBS) Delisted Grant (A) +6,303 $0 EDGAR
2014-07-01 LISATA THERAPEUTICS, INC. (NBS) Delisted Grant (A) +279 $1.5K EDGAR
2014-01-03 LISATA THERAPEUTICS, INC. (NBS) Delisted Grant (A) — $0 EDGAR
2013-08-20 LISATA THERAPEUTICS, INC. (NBS) Delisted Grant (A) +5,000 $0 EDGAR
2012-06-07 AIM ImmunoTech Inc. (HEB) Delisted Other (J) — $0 EDGAR
2009-12-08 AIM ImmunoTech Inc. (HEB) Delisted Buy (P) +2,500 $1.6K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.